Gonadorelin vs HCG
Extensively Studied vs FDA Approved
compatible Often used as alternative to hCG for testicular stimulation during TRT.
Molecular Data
Gonadorelin HCG
Weight 1,182.3 Da 36,700 Da
Half-life 2-4 minutes 24-36 hours
Chain 10 amino acids 237 amino acids (alpha: 92, beta: 145)
Type Decapeptide Heterodimeric glycoprotein
Key Benefits
Gonadorelin
01 Stimulates natural testosterone production
02 Maintains testicular function during hormone therapy
03 Supports fertility in hypogonadal conditions
04 FDA-approved for diagnostic and therapeutic use
05 Can restore LH and FSH pulsatility
06 Alternative to hCG for testicular stimulation
07 Preserves endogenous hormone production
HCG
01 Maintains testicular function during TRT
02 Preserves fertility and prevents testicular atrophy
03 Stimulates endogenous testosterone production
04 Induces ovulation in women
05 FDA-approved for multiple indications
06 Well-established safety profile
Dosing Protocols
Gonadorelin
100-200 mcg for single injections; 5-20 mcg per pulse for pulsatile therapy / 2-3 times weekly for fertility/TRT support; every 90-120 minutes for pulsatile therapy; single dose for diagnostic
Diagnostic testing 100 mcg Single injection
Fertility support 50-100 mcg 2-3x weekly
Pulsatile therapy 5-20 mcg per pulse Every 90-120 min
TRT adjunct 100-200 mcg 2-3x weekly
HCG
250-1500 IU (lower for TRT adjunct, higher for fertility) / 2-3 times weekly, or every other day for lower doses
TRT Adjunct (Low) 250-500 IU Every other day
TRT Adjunct (Standard) 500-1000 IU Twice weekly
HCG Monotherapy 1500-2000 IU 2-3x weekly
Fertility (with FSH) 1500-2000 IU 2-3x weekly
Cryptorchidism (Pediatric) 1000-5000 IU 2-3x weekly for 3-4 weeks
Ovulation Trigger (Female) 5000-10,000 IU Single dose
PCT Protocol 1000-1500 IU Every other day for 2-3 weeks
Side Effects
Gonadorelin
Injection site reactions
Headache
Flushing
Nausea
Abdominal discomfort
HCG
Gynecomastia (breast tenderness/swelling) due to increased estrogen
Headaches, irritability, and mood swings (especially initially)
Fluid retention and edema
Potential antibody formation with long-term use
Contraindications
Hormone-sensitive tumors
Pregnancy
Hypersensitivity to GnRH or analogs
Conditions worsened by sex hormone release
Hormone-sensitive cancers (prostate, breast)
Pregnancy (except as prescribed)
Precocious puberty risk in children
Research Evidence
Gonadorelin HCG
Status Extensively Studied FDA Approved
References 3 studies 5 studies
FDA Approved Yes Yes
More comparisons: Kisspeptin
This comparison is for educational and research purposes only. Consult a healthcare professional before use.